Impax Laboratories Inc (IPXL.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|66||Independent Chairman of the Board|
|56||2017||President, Chief Executive Officer, Director|
|49||2012||Chief Financial Officer, Senior Vice President - Finance|
|53||2016||President - Generics Division|
|64||2008||President - Impax Specialty Pharmaceutical Division|
- BRIEF-Impax Receives Tentative fda Approval Of Generic Coreg CR (Carvedilol Phosphate) Extended-Release Capsules
- BRIEF-Impax Laboratories says co entered into amendment no. 1 to business combination agreement with Atlas Holdings
- BRIEF-Impax Laboratories says board of co amended and restated bylaws of co
- BRIEF-Impax Q3 adjusted earnings per share $0.23
- BRIEF-Impax gets FDA approval for generic Renvela tablets